Your session is about to expire
← Back to Search
Behavioral Intervention
Preventative CBT for Insomnia
N/A
Recruiting
Led By Philip Cheng, Ph.D.
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether preventative CBT for insomnia can help reduce the severity and progression of acute insomnia and depression, and to understand what factors may play a role in developing insomnia and/or engaging with treatment plans.
Who is the study for?
This trial is for adults with a low income or education level who are starting to have trouble sleeping and feel worried about it. It's not for those under 18, people who can't participate, or if they have other untreated sleep issues or serious health problems.
What is being tested?
The study tests whether a one-time virtual therapy session of preventative Cognitive Behavioral Therapy for Insomnia (pCBT-I) can reduce the severity of early insomnia symptoms and prevent them from getting worse.
What are the potential side effects?
Since pCBT-I is a type of talk therapy, there aren't typical medication side effects. However, discussing sleep issues might temporarily increase worry or awareness about sleep patterns.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to one year post-treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to one year post-treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Cases of Clinically Significant Depression
Cases of DSM-5 Insomnia
Depression Severity
+1 moreSecondary study objectives
Physical Environment
Sociocultural Environment
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Preventative Cognitive Behavioral Therapy for InsomniaExperimental Treatment1 Intervention
Participants in this group will complete daily sleep diary entries for one week, and then have a telehealth pCBT-I session with a nurse coach, where they will receive personalized sleep recommendations to improve sleep quality.
Group II: Digital Sleep Education ControlActive Control1 Intervention
Participants in this group will receive digital sleep education, including tips on how to improve your sleep via interactive email. These materials are selected to help prevent chronic insomnia.
Find a Location
Who is running the clinical trial?
University of MichiganOTHER
1,863 Previous Clinical Trials
6,441,251 Total Patients Enrolled
10 Trials studying Insomnia
1,457 Patients Enrolled for Insomnia
Henry Ford Health SystemLead Sponsor
311 Previous Clinical Trials
2,176,113 Total Patients Enrolled
10 Trials studying Insomnia
1,434 Patients Enrolled for Insomnia
Philip Cheng, Ph.D.Principal InvestigatorHenry Ford Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have severe health or mental health conditions that I haven't treated.I am not willing or able to participate in the trial.I am under 18 years old.I have trouble sleeping and it worries or distresses me.I do not have conditions like bipolar or seizures that could affect therapy.I have sleep issues other than insomnia that haven't been treated.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Preventative Cognitive Behavioral Therapy for Insomnia
- Group 2: Digital Sleep Education Control
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Insomnia Patient Testimony for trial: Trial Name: NCT05523726 — N/A